Clinical Trials Sponsored by Consumer Reports

Total 611 results

Lithuanian Sports University

Completed

The Effect of Manual Therapy and Therapeutic Exercises on Pain and Functional Status in Persons With Low Back Pain

Low Back Pain

Lithuania
Lithuanian Sports University

Completed

Effects of Calorie Restriction and Cold Stimuli on Health-related Indicators, Cognitive and Motor Functions

Fasting | Cold Exposure | Calorie Deficiency

Lithuania
Lithuanian Sports University

Completed

Effect of Kinesio Taping and Sham Taping in Knee Osteoarthritis (OA)

Osteoarthritis

Lithuania
Lithuanian Sports University

Completed

The Effect of Tai Chi Chuan in Older Adults

Healthy Aging | Cognitive Function | Motor Learning

Lithuania
Repros Therapeutics Inc.

Completed

A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene

Obesity | Acquired Hypogonadotropic Hypogonadism

United States
Repros Therapeutics Inc.

Completed

A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Uterine Fibroids

United States
Repros Therapeutics Inc.

Completed

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

Uterine Fibroids

United States
Repros Therapeutics Inc.

Completed

To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal

Pharmacokinetics

United States
Repros Therapeutics Inc.

Completed

Comparison of Two Formulations of Proellex for Oral Administration

Healthy

United States
Repros Therapeutics Inc.

Completed

Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids

Uterine Fibroids

United States
Repros Therapeutics Inc.

Completed

Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults

Impaired Liver Function

United States
Repros Therapeutics Inc.

Terminated

Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids

Uterine Fibroids

United States
Repros Therapeutics Inc.

Terminated

Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Uterine Fibroids

United States, Mexico
Repros Therapeutics Inc.

Terminated

Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids

Uterine Fibroids

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal

Normal Volunteers
Repros Therapeutics Inc.

Completed

Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males

Drug-drug Interaction

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism (ZA-003Ext)

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Withdrawn

Open-Label Extension Study to ZPE-202

Endometriosis

United States
Repros Therapeutics Inc.

Completed

A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203

Hypogonadism | Low Testosterone

United States
McNeil AB

Withdrawn

A Study of Butamirate Citrate Syrup Versus (vs) Sinecod Syrup (Vanilla) in Adult Healthy Study Volunteers

Healthy

Russian Federation
Central Medicare Sdn. Bhd.
Consumer Product Testing Company, Inc.

Completed

Skin Sensitization Test (Modified Draize-95 Test)

Skin Sensitisation

United States
McNeil AB

Completed

A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

Nasal Congestion

Russian Federation
McNeil AB

Completed

A Comparison of Three Medications to Treat Diarrhea in Adults.

Diarrhea

India, Mexico
McNeil AB

Completed

Bioequivalence Between a Racecadotril Capsule and Film-Coated Tablet (FCT) to Treat Diarrhea in Adults

Antidiarrheals

Canada
McNeil AB

Completed

Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum

Tobacco Dependence

Sweden
McNeil AB

Completed

Study to Compare the Pharmacokinetics Profiles of Four Racecadotril Products

Diarrhea

Canada
McNeil AB

Completed

Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge

Smoking Cessation

Sweden
McNeil AB

Completed

Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in Stores

Pain

Sweden
McNeil AB

Completed

A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common Cold

Common Cold

United Kingdom
Consumer Wellness Solutions
Oklahoma Tobacco Settlement Endowment Trust (TSET)

Completed

Oklahoma Weight Concerns Quitline: a Randomized Cessation Trial (OKRCT)

Smoking

United States
Lithuanian Sports University

Completed

Electrostimulation and PFMT for Stress Urinary Incontinence

Urinary Incontinence, Stress

Lithuania
Lithuanian Sports University

Completed

Physiotherapy in Knee Osteoarthritis

Knee Osteoarthritis

Lithuania
Lithuanian Sports University

Completed

Physiotherapy in Stress Urinary Incontinence

Urinary Incontinence,Stress

Lithuania
Lithuanian Sports University

Completed

Balance and Leg Function After Hip Replacement

Hip Injuries | Hip Replacement | Coxarthrosis

Lithuania
Lithuanian Sports University

Completed

10-week Yoga Practice Effect on Cognitive and Motor Function in Older Adults (BDNF)

Aging | Healthy Aging

Lithuania
Repros Therapeutics Inc.

Terminated

An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Uterine Fibroids

United States
Repros Therapeutics Inc.

Completed

Proellex® Pharmacokinetic Bridging Study II (PK)

Healthy

United States
Repros Therapeutics Inc.

Completed

Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism

Effect of Treatment on Bone Mineral Density

United States
Repros Therapeutics Inc.

Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Terminated

Study to Evaluate Menses Induction in Women Administered Proellex

Amenorrhea

United States
Repros Therapeutics Inc.

Terminated

Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females

Renal Impairment

United States
Repros Therapeutics Inc.

Terminated

Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

Endometriosis

United States
Repros Therapeutics Inc.

Completed

Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects

Drug Interactions

United States
Repros Therapeutics Inc.

Terminated

Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids

Uterine Fibroids

United States
Repros Therapeutics Inc.

Terminated

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

Anemia | Uterine Fibroids

Mexico

3

Subscribe